150 related articles for article (PubMed ID: 34046939)
21. CircFAT1 facilitates cervical cancer malignant progression by regulating ERK1/2 and p38 MAPK pathway through miR-409-3p/CDK8 axis.
Zhou B; Li T; Xie R; Zhou J; Liu J; Luo Y; Zhang X
Drug Dev Res; 2021 Dec; 82(8):1131-1143. PubMed ID: 33818788
[TBL] [Abstract][Full Text] [Related]
22. Exosomal circDNER enhances paclitaxel resistance and tumorigenicity of lung cancer via targeting miR-139-5p/ITGB8.
Li J; Zhu T; Weng Y; Cheng F; Sun Q; Yang K; Su Z; Ma H
Thorac Cancer; 2022 May; 13(9):1381-1390. PubMed ID: 35396925
[TBL] [Abstract][Full Text] [Related]
23. Circ_0061140 knockdown inhibits tumorigenesis and improves PTX sensitivity by regulating miR-136/CBX2 axis in ovarian cancer.
Zhu J; Luo JE; Chen Y; Wu Q
J Ovarian Res; 2021 Oct; 14(1):136. PubMed ID: 34649611
[TBL] [Abstract][Full Text] [Related]
24. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
Du G; Cao D; Meng L
Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
[TBL] [Abstract][Full Text] [Related]
25. LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis.
Leng W; Liu Q; Zhang S; Sun D; Guo Y
Cancer Biol Ther; 2020 Nov; 21(11):1072-1080. PubMed ID: 33138677
[TBL] [Abstract][Full Text] [Related]
26. Effect of rs67085638 in long non-coding RNA (CCAT1) on colon cancer chemoresistance to paclitaxel through modulating the microRNA-24-3p and FSCN1.
Xiao ZS; Zhao L; Zhang XN; Li HX; Yin ZH
J Cell Mol Med; 2021 Apr; 25(8):3744-3753. PubMed ID: 33709519
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA HOXC-AS3 enhances the progression of cervical cancer via activating ErbB signaling pathway.
Zhao R; Song J; Jin Y; Liu Y
J Mol Histol; 2021 Oct; 52(5):991-1006. PubMed ID: 34387789
[TBL] [Abstract][Full Text] [Related]
29. Circular RNA circ_0011385 promotes cervical cancer progression through competitively binding to miR-149-5p and up-regulating SOX4 expression.
Xu AL; Wang WS; Zhao MY; Sun JN; Chen XR; Hou JQ
Kaohsiung J Med Sci; 2021 Dec; 37(12):1058-1068. PubMed ID: 34369654
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p.
Lin L; Xin B; Jiang T; Wang XL; Yang H; Shi TM
Mol Cell Biochem; 2020 Dec; 475(1-2):1-13. PubMed ID: 32740791
[TBL] [Abstract][Full Text] [Related]
31. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
[TBL] [Abstract][Full Text] [Related]
32. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
Huang Y; Luo F
IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
[TBL] [Abstract][Full Text] [Related]
33. Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro.
Yu J; Zhao Y; Liu C; Hu B; Zhao M; Ma Y; Jiang J
Clin Transl Oncol; 2020 Jan; 22(1):60-69. PubMed ID: 31093891
[TBL] [Abstract][Full Text] [Related]
34. Circ-ATP8A2 promotes cell proliferation and invasion as a ceRNA to target EGFR by sponging miR-433 in cervical cancer.
Ding L; Zhang H
Gene; 2019 Jul; 705():103-108. PubMed ID: 31029604
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo.
Fu J; Zhang Y; Wang M; Hu J; Fang Y
J Gene Med; 2021 Dec; 23(12):e3382. PubMed ID: 34350661
[TBL] [Abstract][Full Text] [Related]
36. Hsa_circ_0102171 aggravates the progression of cervical cancer through targeting miR-4465/CREBRF axis.
Tang X; Wen X; Li Z; Wen D; Lin L; Liu J; Li M
J Cell Physiol; 2021 Jul; 236(7):4973-4984. PubMed ID: 33615474
[TBL] [Abstract][Full Text] [Related]
37. Circ_0000388 Exerts Oncogenic Function in Cervical Cancer Cells by Regulating miR-337-3p/
Meng QH; Li Y; Kong C; Gao XM; Jiang XJ
Cancer Biother Radiopharm; 2021 Feb; 36(1):58-69. PubMed ID: 32119786
[No Abstract] [Full Text] [Related]
38. miR-133a inhibits cervical cancer growth by targeting EGFR.
Song X; Shi B; Huang K; Zhang W
Oncol Rep; 2015 Sep; 34(3):1573-80. PubMed ID: 26134491
[TBL] [Abstract][Full Text] [Related]
39. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
40. miR-145-5p attenuates paclitaxel resistance and suppresses the progression in drug-resistant breast cancer cell lines.
Guan X; Guan Y
Neoplasma; 2020 Sep; 67(5):972-981. PubMed ID: 32412771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
